Dr. Kimberly Brewer, PhD
- Breast Cancer
- Cerebral Tumors
- Infection and Immunity
Dr. Brewer's lab focuses on the use of molecular imaging to evaluate novel drugs and improve their translation into clinical care; and to develop novel prognostic and diagnostic biomarkers that can be used in preclinical and/or clinical environments. Research in the lab ranges from development of novel acquisition techniques and analysis tools for molecular imaging to studying and testing novel cancer therapeutics in preclinical models.
As the scientific lead of the Biomedical MRI Research Lab (BMRL), a core lab in the Biomedical Translational Imaging Centre (BIOTIC; www.bioticimaging.ca), Dr. Brewer is interested in using a wide range of molecular imaging tools to improve translation of novel therapies from the bench to the bedside. Her research is highly interdisciplinary crossing several fields and departments.
The infrastructure in the BMRL includes preclinical MRI, PET/CT, SPECT and PET/MRI. Students interested in interdisciplinary research projects, particularly in the areas of imaging of cancer therapies, developing imaging and analysis tools for cell tracking, and multi-modality PET/MRI imaging should contact Dr. Brewer about ongoing research opportunities.